Corticosteroids in the management of central nervous system tumours

Archives of Disease in Childhood

Volumn 76, Issue 1, 1997, Pages 76-78

  Glaser, Adam W ^a,c   Buxton, Neil ^b   Walker, David ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b Dept of Paediatric Neurosurgery ^*

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID;

CENTRAL NERVOUS SYSTEM TUMOR; CHILD; EDEMA; HUMAN; INTRACRANIAL PRESSURE; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SHORT SURVEY; SIDE EFFECT;

EID: 8044226012     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.76.1.76     Document Type: Short Survey

References (27)

1. Stiller CA. Aetiology and epidemiology of childhood cancer. In: Plowman PN, Pinkerton CR, eds. Paediatric oncology. Clinical practice and controversies. 1st Ed. London: Chapman and Hall, 1992:1-24.
2. Keith HM. Brain tumours in children. Pediatrics 1949;3: 839-44.
3. Stiller CA. Population based survival rates for childhood cancer in Britain, 1980-91. BMJ 1994;309:1612-6.
4. Kofman S. Treatment of cerebral metastases from breast carcinoma with prednisolone. JAMA 1957;163:1473-6.
5. Albright AL. Surgery in the management of childhood brain tumours. In: Deutsch M, ed. Management of childhood brain tumours. Boston: Kluwer Academic Publishers, 1990:175-86.
6. Long DM, Hartmann JF, French LA. The response of cerebral oedema to glucocorticoid administration: an electron microscopic study. Neurology 1966;16:521-8.
7. Weissman DE. Glucocorticoid treatment for brain metastases and epidural spinal cord compression: a review. J Clin Oncol 1988;6:543-51.
8. Shapiro WR, Posner JB. Corticosteroid hormones; effects in an experimental brain tumour. Arch Neurol 1974;30:217-21.
9. Eisenberg HM, Barlow CF, Lorenzo AV. Effect of dexamethasome on altered brain vascular permeability. Arch Neurol 1970;23:18-22.
10. Miller JD, Leech P. Effects of mannitol and steroid therapy on intracranial volume-pressure relationships in patients. J Neurosurg 1975;42:274-81.
11. Mealy J, Chen TT, Schanz GP. The effects of dexamethasome and methylprednisolone on cell cultures of human glioblastoma. J Neurosurg 1971;34:324-34.
12. Sherbert GV, Lakshmi MS, Haddah S. Does dexamethasome inhibit the growth of human gliomas? J Neurosurg 1977;47:864-70.
13. Maciunas RJ, Mericle RA, Sneed CL, et al. Determination of the lethal dose of dexamethasome for early passage in vitro human gliblastoma cell cultures. Neurosurgery 1993; 33:485-8.
14. Freshney RI. Effects of glucocorticoids on glioma cells in culture. Minireview on cancer research. Experimental Cell Biology 1984;52:286-92.
15. Zager RF, Frisby SA, Oliverio VT. Cellular transport and antitumor action of methotrexate with several drugs. Proceedings of the American Academy of Cancer Research 1972;13:33.
16. Edgeworth J, Bullock P, Bailey P, Gallagher A, Crouchman M. Why are brain tumours still being missed? Arch Dis Child 1996;74:148-51.
17. Flores LE, Williams DL, Bell BA, O'Brien M, Ragab A. Delay in the diagnosis of pediatric brain tumours. Am J Dis Child 1986;140:684-6.
18. Saha V, Love S, Eden T, Micallef-Eynaud P, MacInlay G. Determinants of symptom interval in childhood cancer. Arch Dis Child 1993;68:771-4.
19. Glaser AW, Buxton N, Hewitt M, Punt J, Walker DA. The role of steroids in central nervous system malignancies. Br J Neurosurg 1996;10:123.
20. Hayes RC, Murad F. Adrenocorticotrophic hormone; adrenocotrical steroids and their analogs; inhibitors of adrenocortical steroid biosynthesis. In: Goodman Gilman A, Goodman LS, Rall TW, Murad F, eds. The pharmacological basis of therapeutics. 7th Ed. London: Collier MacMillan Publishers, 1985:1459-89.
21. Barr RD, Petrie C, Furlong W, Rothney M, Feeny D. Health-related quality of life during post-induction chemotherapy in children with acute lymphoblastic leukaemia in remission. Med Pediatr Oncol 1996;27:240.
22. Astelm J. Elizabeth and Alexandra's story. Child Care Health Dev 1995;21:369-75.
23. Messer J, Reitman D, Sacks HS, Smith H Jr, Chalmers TC. Association of adrenocorticosteroid therapy and peptic ulcer disease. N Engl J Med 1983;309:21-4.
24. Foot ABM, Hayes C. Audit of guidelines for effective control of chemotherapy and radiotherapy induced emesis. Arch Dis Child 1994;71:475-80.
25. Weissman DE, Janjan NA, Erickson B, et al. Twice-daily tapering dexamethasome treatment during cranial radiation for newly diagnosed brain metastases. Clinical study. J Neurooncol 1991;11:235-9.
26. Vecht CJ, Hovestadt A, Verbiest HBC, van Vliet JJ, van Putten WLJ. Dose-effect relationship of dexamethasome on Karnofsky performance in metastatic brain tumors: a randomised study of doses of 4,8 and 16 mg per day. Neurology 1994;44:675-80.
27. Soyka LF. Treatment of the nephrotic syndrome in childhood; use of alternate day prednisolone regimen. Am J Dis Child 1967;113:693-701.